Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-041326
Filing Date
2014-11-12
Accepted
2014-11-12 16:32:25
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2014 form10q.htm 10-Q 885622
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 26516
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 13045
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 12611
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7158
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 7767
13 image00001.jpg GRAPHIC 65256
  Complete submission text file 0001140361-14-041326.txt   10429083

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rnn-20140930.xml EX-101.INS 2167159
8 XBRL TAXONOMY EXTENSION SCHEMA rnn-20140930.xsd EX-101.SCH 62624
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rnn-20140930_cal.xml EX-101.CAL 53996
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rnn-20140930_def.xml EX-101.DEF 134318
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rnn-20140930_lab.xml EX-101.LAB 389930
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rnn-20140930_pre.xml EX-101.PRE 327365
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 141214517
SIC: 2834 Pharmaceutical Preparations